These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 8631304

  • 1. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
    Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M, Vousden KH.
    EMBO J; 1996 Feb 15; 15(4):827-38. PubMed ID: 8631304
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function.
    Ludwig RL, Bates S, Vousden KH.
    Mol Cell Biol; 1996 Sep 15; 16(9):4952-60. PubMed ID: 8756654
    [Abstract] [Full Text] [Related]

  • 4. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest.
    Ryan KM, Vousden KH.
    Mol Cell Biol; 1998 Jul 15; 18(7):3692-8. PubMed ID: 9632751
    [Abstract] [Full Text] [Related]

  • 5. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B, Crook T, Inga A, Resnick MA, Iggo R, Fronza G.
    Oncogene; 2001 Jun 14; 20(27):3573-9. PubMed ID: 11429705
    [Abstract] [Full Text] [Related]

  • 6. Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis.
    Wang Y, Okan I, Pokrovskaja K, Wiman KG.
    Oncogene; 1996 Jun 20; 12(12):2731-5. PubMed ID: 8700534
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells.
    Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA.
    Oncogene; 1995 Aug 03; 11(3):493-504. PubMed ID: 7630633
    [Abstract] [Full Text] [Related]

  • 9. Role of the ATPase domain of the Cockayne syndrome group B protein in UV induced apoptosis.
    Balajee AS, Proietti De Santis L, Brosh RM, Selzer R, Bohr VA.
    Oncogene; 2000 Jan 27; 19(4):477-89. PubMed ID: 10698517
    [Abstract] [Full Text] [Related]

  • 10. The p53 tumor suppressor gene and gene product.
    Levine AJ.
    Princess Takamatsu Symp; 1989 Jan 27; 20():221-30. PubMed ID: 2488233
    [Abstract] [Full Text] [Related]

  • 11. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest.
    Guillouf C, Graña X, Selvakumaran M, De Luca A, Giordano A, Hoffman B, Liebermann DA.
    Blood; 1995 May 15; 85(10):2691-8. PubMed ID: 7742528
    [Abstract] [Full Text] [Related]

  • 12. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 13. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL, Sinha UK.
    Head Neck; 2006 Jan 25; 28(1):15-23. PubMed ID: 16302195
    [Abstract] [Full Text] [Related]

  • 14. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
    Tarunina M, Grimaldi M, Ruaro E, Pavlenko M, Schneider C, Jenkins JR.
    Oncogene; 1996 Aug 01; 13(3):589-98. PubMed ID: 8760300
    [Abstract] [Full Text] [Related]

  • 15. The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality.
    Johnson TM, Hammond EM, Giaccia A, Attardi LD.
    Nat Genet; 2005 Feb 01; 37(2):145-52. PubMed ID: 15654339
    [Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M, Yamashita T, Shindoh M, Segawa K, Takahashi S, Furuta I, Fujimoto S, Fujinaga K.
    Mol Carcinog; 1999 Sep 01; 26(1):44-52. PubMed ID: 10487521
    [Abstract] [Full Text] [Related]

  • 17. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
    Hansen RS, Braithwaite AW.
    Oncogene; 1996 Sep 05; 13(5):995-1007. PubMed ID: 8806689
    [Abstract] [Full Text] [Related]

  • 18. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
    Zacharatos PV, Gorgoulis VG, Kotsinas A, Manolis EN, Liloglou T, Rassidakis AN, Kanavaros P, Field JD, Halazonetis T, Kittas C.
    Anticancer Res; 1999 Sep 05; 19(1A):579-87. PubMed ID: 10226602
    [Abstract] [Full Text] [Related]

  • 19. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.
    Gottlieb E, Lindner S, Oren M.
    Cell Growth Differ; 1996 Mar 05; 7(3):301-10. PubMed ID: 8838860
    [Abstract] [Full Text] [Related]

  • 20. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
    Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE.
    Cell Growth Differ; 1995 Nov 05; 6(11):1395-403. PubMed ID: 8562478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.